Genesis HealthCare (GEN) Tops Q4 EPS by 2c
Genesis HealthCare (NASDAQ: GEN) reported Q4 EPS of $0.45, $0.02 better than the analyst estimate of $0.43. Revenue for the quarter came in at $936 million versus the consensus estimate of $933 million.
For earnings history and earnings-related data on Genesis HealthCare (GEN) click here.
